Bendamustine in combination with thalidomide and prednisone in patients with refractory or relapsed multiple myeloma. preliminary results of a phase I clinical trial

被引：0
|
作者：
Pönisch, W
Rozanski, M
Leiblein, S
Goldschmidt, H
Wegner, A
Niederwieser, D
机构：
[1] Univ Leipzig, Dept Haematol Oncol, D-7010 Leipzig, Germany
[2] Ribosepharm GmbH, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
584
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [1] Lenalidomide in combination with Bendamustine and Prednisolone (RBP) in patients with refractory or relapsed multiple myeloma. Preliminary results of a phase I clinical trial
    Poenisch, W.
    Heyn, S.
    Wagner, I
    Mohren, M.
    Hoffmann, F. A.
    Schueler, F.
    Al-Ali, H. K.
    Jaekel, N.
    Niederwieser, D.
    ONKOLOGIE, 2010, 33 : 156 - 156
  • [2] Bendamustine in combination with thalidomide and prednisolone (BPT) in patients with refractory or relapsed multiple myeloma (MM): Preliminary results of a phase I clinical trial.
    Poenisch, W
    Rozanski, M
    Leiblein, S
    Goldschmidt, H
    Wegner, A
    Niederwieser, D
    BLOOD, 2004, 104 (11) : 307B - 307B
  • [3] Bendamustine in combination with thalidomide and prednisolone (BPT) in patients with refractory or relapsed multiple myeloma: Results of a phase I clinical trial.
    Poenisch, W.
    Rozanski, M.
    Hoffmann, F.
    Boldt, T.
    Schwarzer, A.
    Ruffert, U.
    Rohrberg, R.
    Kreibich, U.
    Niederwieser, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 451S - 451S
  • [4] A phase I/II trial on melphalan, prednisone, thalidomide and defribotide combination in relapsed/refractory multiple myeloma patients
    Palumbo, Antonio
    Larocca, Alessandra
    Rus, Cecilia
    Gay, Francesca
    Rossi, Davide
    Pregno, Patrizia
    Falco, Patrizia
    Avonto, Ilaria
    Magarotto, Valeria
    Cavallo, Federica
    Iacobelli, Massimo
    Gaidano, Gianluca
    Mitsiades, Constantine
    Richardson, Paul G.
    Anderson, Kenneth C.
    Boccadoro, Mario
    BLOOD, 2007, 110 (11) : 797A - 797A
  • [5] Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial
    Ponisch, Wolfram
    Heyn, Simone
    Wagner, Ina
    Mohren, Martin
    Hoffmann, Franz-Albert
    Schueler, Frank
    Schmalfeld, Marion
    Al-Ali, Haifa K.
    Jaekel, Nadja
    Niederwieser, Dietger W.
    BLOOD, 2010, 116 (21) : 823 - 824
  • [6] Combination of Lenalidomide, Melphalan, Prednisone and Thalidomide (RMPT) in Relapsed/Refractory Multiple Myeloma: Results of a Multicenter Phase II Clinical Trial
    Palumbo, Antonio
    Falco, Patrizia
    Sanpaolo, Grazia
    Falcone, Antonietta
    Ferderico, Vincenzo
    Canepa, Letizia
    Crugnola, Monica
    Baldini, Luca
    Larocca, Alessandra
    Magarotto, Valeria
    Petrucci, Maria Teresa
    Boccadoro, Mario
    BLOOD, 2008, 112 (11) : 321 - 321
  • [7] Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial
    Palumbo, Antonio
    Larocca, Alessandra
    Genuardi, Mariella
    Kotwica, Katarzyna
    Gay, Francesca
    Rossi, Davide
    Benevolo, Giulia
    Magarotto, Valeria
    Cavallo, Federica
    Bringhen, Sara
    Rus, Cecilia
    Masini, Luciano
    Iacobelli, Massimo
    Gaidano, Gianluca
    Mitsiades, Constantine
    Anderson, Kenneth
    Boccadoro, Mario
    Richardson, Paul
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1144 - 1149
  • [8] A Phase I Clinical Trial Testing the Combination of Bortezomib and Tipifarnib in Relapsed/Refractory Multiple Myeloma.
    Lonial, Sagar
    Francis, Dixil
    Karanes, Chatchada
    Trudel, Suzanne
    Dollard, Akari M.
    Aceo, Fermin
    Gul, Engin
    Kakar, Sumeet
    Krishnan, Amrita Y.
    Reece, Donna E.
    Harvey, R. Donald
    Kaufman, Jonathan L.
    BLOOD, 2009, 114 (22) : 1481 - 1481
  • [9] Lenalidomid combined with Bendamustine, Prednisolone (RBP) in patients with refractory or relapsed multiple myeloma. Final results of a phase I clinical trial -OSHO - #077
    Poenisch, W.
    Heyn, S.
    Wagner, I
    Mohren, M.
    Hoffmann, F. A.
    Lange, T.
    Schmalfeld, M.
    Zehrfeld, T.
    Schwarzer, A.
    Winkelmann, C.
    Edelmann, T.
    Hebenstreit, K.
    Al-Ali, H. K.
    Jaekel, N.
    Niederwieser, D.
    ONKOLOGIE, 2012, 35 : 160 - 160
  • [10] COMBINED BENDAMUSTINE, PREDNISOLONE AND LENALIDOMIDE (RBP) IN PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA. FINAL RESULTS OF A PHASE I CLINICAL TRIAL - OSHO - #077
    Poenisch, W.
    Heyn, S.
    Wagner, I.
    Mohren, M.
    Hoffmann, F. A.
    Lange, T.
    Schmalfeld, M.
    Zehrfeld, T.
    Schwarzer, A.
    Winkelmann, C.
    Edelmann, T.
    Roehrborn, R.
    Al-Ali, H.
    Jaekel, J.
    Niederwieser, D.
    HAEMATOLOGICA, 2012, 97 : 348 - 348
12345